Title: Nirogi R, et al. Discovery and Development of 1-[(2-Bromophenyl)sulfonyl-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT6) Receptor Antagonist for Potential Treatment of Alzheimer's Disease. J Med Chem. 2017 Mar 9;60(5):1843-1859.